Q1 2024
QUARTER ENDED MAR 31, 2024
Download PDF
Q2 2024
QUARTER ENDED JUN 30, 2024
Q3 2024
QUARTER ENDED SEP 30, 2024
FY 2023
FISCAL YEAR ENDED DEC 31, 2023
Earnings Release
Q3 2023
QUARTER ENDED SEP 30, 2023
Q2 2023
QUARTER ENDED JUN 30, 2023
Q1 2023
QUARTER ENDED MAR 31, 2023
FY 2022
FISCAL YEAR ENDED DEC 31, 2022
Q3 2022
QUARTER ENDED SEP 30, 2022
Q2 2022
QUARTER ENDED JUN 30, 2022
Q1 2022
QUARTER ENDED MAR 31, 2022
FY 2021
FISCAL YEAR ENDED DEC 31, 2021
Q3 2021
QUARTER ENDED SEP 30, 2021
Q2 2021
QUARTER ENDED JUN 30, 2021
Q1 2021
QUARTER ENDED MAR 31, 2021
FY 2020
FISCAL YEAR ENDED DEC 31, 2020
Q3 2020
QUARTER ENDED SEP 30, 2020
Q2 2020
QUARTER ENDED JUN 30, 2020
Q1 2020
QUARTER ENDED MAR 31, 2020
FY 2019
FISCAL YEAR ENDED DEC 31, 2019
Q3 2019
QUARTER ENDED SEP 30, 2019
Q2 2019
QUARTER ENDED JUN 30, 2019
Q1 2019
QUARTER ENDED MAR 31, 2019
FY 2018
FISCAL YEAR ENDED DEC 31, 2018
Q3 2018
QUARTER ENDED SEP 30, 2018
Q2 2018
QUARTER ENDED JUN 30, 2018
© Copyright 2025 Quantum BioPharma. All Rights Reserved. Powered by ACCESS Newswire.
Chris Tyson Executive Vice President MZ North America Direct: 949-491-8235 QNTM@mzgroup.us
www.quantumbiopharma.com/contact
info@quantumbiopharma.com
+1-833-571-1811
55 University Ave. , Suite 1003Toronto, ON, M5J 2H7 Canada
